Day clinic vs. hospital care of pneumonia and severe malnutrition in children under five: a randomised trial.

Objectives: To evaluate the clinical outcomes and costs of managing pneumonia and severe malnutrition in a day clinic (DC) management model (outpatient) vs. hospital care (inpatient).

Methods: Randomised clinical trial where children aged 2 months to 5 years with pneumonia and severe malnutrition were randomly allocated to DC or inpatient hospital care.

Preliminary analysis of the effect of Stevia () in patients with chronic kidney disease (stage I to stage III).

Background: Stevia, (Bertoni), has become an important economic plant for its commercial use as a sweetener. Stevia plays a significant role in the healthcare practice of different cultures and in population. Previous animal and clinical studies demonstrated the efficacy of Stevia against chronic diseases like diabetes and hypertension.

Prediction of seizure outcome in childhood epilepsies in countries with limited resources: a prospective study.

Aim: To identify predictors of seizure control in newly presenting children with epilepsy in countries with limited resources.

Method: Three hundred and ninety children (273 males, 117 females) aged 2 months to 15 years with newly diagnosed epilepsy were enrolled prospectively at first visit to the multidisciplinary clinic at the children's hospital in Dhaka, Bangladesh. Data about seizures, motor disability, psychomotor development, and electroencephalography were obtained.

Escalated regimen of hepatitis B vaccine in childhood hematological malignancies while on chemotherapy.

This prospective study was conducted to find the effective vaccination schedule against hepatitis B virus (HBV) infection for children with hematological malignancies. Sixty patients ages 2-15 years old with hematological malignancies on chemotherapy, negative for hepatitis B surface antigen (HBsAg) and never vaccinated for HBV before, were vaccinated with 40 microg of vaccine at 0, 1 and 2 months. Antibody titers were measured 6 weeks after administration of last dose.